Madrigal Pharmaceuticals (MDGL) Operating Income Growth (3y) (2013 - 2026)
Madrigal Pharmaceuticals (MDGL) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 16.34 Bn | 16.11 Bn | - | -5.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.78% |
| Dec 31, 2025 | 11.26% |
| Sep 30, 2025 | -12.33% |
| Jun 30, 2025 | 12.42% |
| Mar 31, 2025 | -11.26% |
| Dec 31, 2024 | -1.22% |
| Sep 30, 2024 | -22.57% |
| Jun 30, 2024 | -38.08% |
| Mar 31, 2024 | -42.11% |
| Dec 31, 2023 | -25.31% |
| Sep 30, 2023 | -18.79% |
| Jun 30, 2023 | -19.76% |
| Mar 31, 2023 | -27.26% |
| Dec 31, 2022 | -41.74% |
| Sep 30, 2022 | -49.23% |
| Jun 30, 2022 | -45.73% |
| Mar 31, 2022 | -47.03% |
| Dec 31, 2021 | -64.72% |
| Sep 30, 2021 | -77.30% |
| Jun 30, 2021 | -99.07% |